Darunavir/cobicistat
Darunavir/cobicistat (pronunciation: da-ROO-na-veer/ko-bi-SIS-tat) is a combination medication used in the treatment of HIV (Human Immunodeficiency Virus).
Etymology
The name Darunavir is derived from d for Tibotec (the company that discovered it), ar for ARV (antiretroviral), una (one in Spanish, representing the company's aim to produce a once-daily drug), and vir for virus. Cobicistat is a pharmacokinetic enhancer that increases the effectiveness of darunavir by inhibiting the enzyme that metabolizes it in the body.
Usage
Darunavir/cobicistat is used in combination with other antiretroviral medications to control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life.
Related Terms
- Antiretroviral therapy: The use of drugs to manage HIV.
- Pharmacokinetic enhancer: A drug that boosts the effectiveness of another drug.
- Enzyme inhibitor: A substance that reduces the activity of an enzyme.
See Also
External links
- Medical encyclopedia article on Darunavir/cobicistat
- Wikipedia's article - Darunavir/cobicistat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski